Amazon-Wells Fargo Deal Hit Political Obstacles
Puma Biotechnology Announces U.S. FDA Acceptance of New Drug Application for PB272 (Neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer
Fitch Upgrades Dell's Long-Term IDR to 'BB+' on EMC Deal Close; Outlook Stable
Increased regulation could advantage high-tech disrupters and firms with economies of scale, says Morningstar's Jim Sinegal.
Morningstar's Dan Werner and Jim Sinegal see a move toward digital and direct channels.
Stabilizing tuitions, changes to 529 plans, student loan-relief measures, and more should be on your radar.
The Internet giant's network effect, mobile capabilities, and PayPal platform have it positioned for long-term growth, say Morningstar's Matt Coffina and R.J. Hottovy.
Outperformance is increasingly unlikely.
In a fully valued market, a steady hand behind the wheel matters more than ever.
The market decline this past week hasn't left stocks as a whole cheap, but there are growing opportunities for stock selectors.